TACR1 and pancreatic neoplasm: Moreover, it has been demonstrated that the NK-1 receptor expression is increased 25-36-fold in human pancreatic cancer cell lines in comparison with normal controls, and that tumors samples of patients with advanced tumor stages exhibit significantly higher NK-1 receptor levels [33].